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ABSTRAK
Sepsis menyebabkan kadar kematian dan morbiditi pesakit di hospital yang tinggi. 
Kepekatan laktat statik dan kadar pengurangan paras laktat awal dicadangkan sebagai 
faktor utama penentuan kadar kematian pesakit sepsis. Kajian ini mengaplikasikan 
kepekatan laktat dan kadar pengurangan paras laktat pada tempoh enam jam 
pertama di Jabatan Kecemasan untuk meramalkan kadar kematian pesakit sepsis 
selepas 28 hari. Pesakit yang menghidapi sepsis, sepsis teruk dan renjatan sepsis 
yang menerima rawatan di jabatan kecemasan Universiti Kebangsaan Malaysia 
akan dimasukkan dalam kajian ini. Kepekatan laktat static darah pesakit pada masa 
permulaan kemasukan pesakit, pada satu jam dan pada enam jam akan dikaji. 
Pesakit kemudiannya diberi rawatan yang berpatutan mengikut diagnosis sepsis, 
iaitu rawatan piawai atau rawatan awal berasalkan sasaran untuk sepsis. Selepas 
28 hari, pesakit akan dihubungi melalui telefon, emel atau laporan perubatan 
pesakit. Kemudian, pesakit akan dikatogorikan kepada golongan yang hidup atau 
mati. Dalam kajian ini, kepekatan laktat menujukan hubung kait yang erat dengan 
golongan yang mati berbanding dengan golongan yang hidup dalam ketiga-tigaan 
masa, iaitu jam 0, 1 dan 6 (p<0.05). Akan tetapi, kadar pengurangan paras laktat 
tidak menunjukkan sebarang hubung kait dengan kadar kematian pesakit selepas 
28 hari. Kesimpulannya, kepekatan laktat static merupakan petunjuk yang baik 
untuk meramalkan kadar kematian sepsis berbanding dengan kadar pengurangan 
paras laktat. Walaupun kadar pengurangan paras laktat tidak dapat membuktikan 
sebarang hubung kait dengan kadar kematian selepas 28 hari, kajian kami 
menunjukkan ia masih boleh dimanfaatkan sebagai pemantau yang baik semasa 
merawat pesakit sepsis.
Kata kunci:  sepsis, paras laktat, kadar pengurangan laktat, kadar kematian
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ABSTRACT
Sepsis causes high mortality and morbidity. Static lactate concentration and early 
lactate clearance are cited to be a predictor for sepsis survival. This study examined 
the clinical utility of static lactate concentration and early lactate clearance within 
the first six hours of admission in Emergency Department (ED) to predict 28-day 
mortality rate in sepsis patients. Patients who presented with sepsis, severe sepsis or 
septic shock and admitted to ED of Universiti Kebangsaan Malaysia Medical Centre 
were recruited. Blood lactate concentrations were measured upon admission (H0), 
at 1st hour (H1) and 6th hour (H6), respectively. Either standard treatment of sepsis 
or early goal directed therapy was initiated according to sepsis severity. A follow-up 
report was conducted at 28 days via telephone call, e-mail or case notes. Patients 
were later classified into survivor and non-survivor as final outcome. Static lactate 
concentration appeared to be significantly higher for non-survivor as compared to 
the survival group at H0, H1 and H6 (p<0.05). The lactate clearance trend reflects 
no relationship between early lactate clearance and 28-day mortality. Static lactate 
concentration showed a superior predictor for sepsis over early lactate clearance. 
Although early lactate clearance was unable to prove its ability to predict 28-day 
mortality, our findings suggest it can be a useful tool to gauge the resuscitation 
outcome.
Keywords: sepsis, lactate levels, lactate clearance, mortality  
early lactate clearance had also shown 
improvement in the outcome of sepsis 
as well (Fuller & Dellinger 2012; Walker 
et al. 2013) and few other studies had 
shown its prognostic outcome (Varpula 
et al. 2005; Fuller & Dellinger 2012; 
Puskarich et al. 2012). Furthermore, 
lactate clearance has been proposed 
as a better therapeutic guidance for 
severe sepsis and septic shock patient’s 
management (Kruse 1999; Shapiro et 
al. 2005; Wang et al. 2006; Jones et al. 
2010; Jansen et al. 2010; Jones 2011). 
Lactate clearance also suggested being 
less invasive and more cost effective 
in treating sepsis (Varpula et al. 2005). 
However, some studies had point out 
the flaw of static lactate and lactate 
clearance as risk stratification. Many 
INTRODUCTION
Early identification and treatment of 
sepsis are essential to improve the 
outcome of sepsis patient or patient 
with impending sepsis (Rivers et al. 
2001; Shapiro et al. 2005). Static lactate 
elevation had been utilized as a key to 
predict mortality rate of sepsis patients 
in emergency department (ED) (Bakker 
et al. 1991; Aduen et al. 1994; Bakker 
et al. 1996; Bakker 2001; Dellinger 
et al. 2004a; Varpula et al. 2005; 
Marty et al. 2013). Current Surviving 
Sepsis Campaign (Dellinger et al. 
2004b; Nguyen et al. 2004) advocates 
measurement of lactate in sepsis patient 
and possible severe sepsis patient to 
guide the further management (Shapiro 
et al. 2005). On the other hand, an 
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sepsis patients are presented with 
normal static lactate (Mizock 2001; 
Dugas et al. 2009; Hernandez et al. 
2011). Static lactate level is inconsistent 
with fluctuation after intervention 
(Hernandez et al. 2011, Rivers et 
al. 2011). However, a research has 
found out that lactate clearance does 
not improve the outcome in septic 
syndrome patients (Jones et al. 2010). 
Another study also proposed that 
lactate clearance should not be used as 
a substitute guideline for management 
severe sepsis and septic shock with 
reasons that inconsistency of static 
lactate is inappropriate risk stratification 
and lactate clearance can be a delayed 
indicator of tissue perfusion with lack of 
understanding on mechanism behind it 
(Marty et al. 2013). In addition, better 
lactate clearance does not necessary 
improved outcome of septic syndrome 
patient (Marik & Bellomo 2013). These 
arguments had triggered us to elucidate 
(a) the association of static lactate and 
lactate clearance at 0 hour, 1 hour 
and 6 hour, respectively with 28-day 
mortality in sepsis syndrome of the 
ED and (b) to examinine for 28-day 
mortality prognostication of static 
lactate level and first six hours lactate 
clearance during admission in ED for 
sepsis syndromes.
MATERIALS AND METHODS
SETTING AND STUDY DESIGN
This was a prospective observation 
study which was performed in ED 
of Universiti Kebangsaan Malaysia 
Medical Centre (UKMMC) from 
March 2014 to May 2014. The study 
population consisted of severe sepsis, 
septic shock and sepsis patients who 
were admitted in ED during the study. 
The initial venous or arterial blood 
serum lactate level at 0 hour, 1st hour 
and 6th hour were measured. After 28 
days, a follow-up was pursued in each 
patient to determine all-cause mortality.
PARTICIPANTS
The inclusion criteria were consented 
patients, suspected sepsis patients who 
older than 17-year-old with two or 
more criteria of systemic inflammatory 
response syndrome. Besides that, 
patients with systolic blood pressure 
(SBP) less than 90 mmHg after 500 
to 1000 ml crystalloid fluid challenge 
also recruited in our study. However, 
the exclusion criteria are the patients 
who were partially treated with 
antibiotics for more than three days, 
or patient deceased during the period 
of recruitment. Patient transferred out 
to other hospitals without completing 
the six hours management were also 
excluded from this study.
VARIABLES
Sepsis is defined as infection with 
two or more criteria of Systemic 
Inflammatory Response Syndrome 
(SIRS). In addition, definition of severe 
sepsis is sepsis associated with at least 
one tissue hypo-perfusion or present 
of sepsis-induced organ dysfunction. 
Furthermore, septic shock which is also 
known as hypotension induce by sepsis 
is defined with a mean arterial pressure 
< 70 mm Hg or a SBP decrease more 
than 40 mm Hg or < 2 SD below 
normal, or systolic blood pressure (SBP) 
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less than 90 mm Hg for age, which 
there is no other causes responsible for 
the hypotension despite adequate fluid 
resuscitation. Moreover, the definition 
of sepsis induced tissue hypo-perfusion 
is oliguria, septic shock, or elevated 
lactate (Table 1). Lactate clearance is 
defined as blood lactates reduced by 
10% or more from the initial blood 
lactate levels. It can be calculated by 
using the formula as follows: 
[(LACinitial –LACfinal)/ LACinitial] x 100%]
STUDY SOURCES/ MEASUREMENT
Once the patient has fulfilled the 
inclusion and exclusion criteria, blood 
lactate was withdrawn (2 ml) at H0, H1 
and H6. The samples were collected 
into sodium fluoride/ potassium oxalate 
(grey top) test tube. After that, the blood 
was centrifuged (1300G, 10 minutes) 
and sent for lactate analysis. A standard 
treatment of sepsis was initiated at 0 
hour for patients who were identified 
as sepsis. For sepsis-induced hypo-
perfusion patients, they were treated 
Table 1: Definition of sepsis, severe sepsis, septic shock and sepsis induced 
hypoperfusion
Definition
Sepsis SIRS criteria (2 or more) + a source of infection
1. Temperature ≥38˚C or ≤ 36˚C
2. White blood cell count  ≥12 000 or ≤4000/mm³
3. Heart rate ≥ 90 beats per minute
4. Respiratory rate ≥ 20 breaths per minute or Pa CO2 < 32mmHg
Severe Sepsis Sepsis with 1 organ dysfunction
1. Arterial hypoxemia (PaO2 / FiO2 < 300  Acute Lung Injury) (PaO2/     
    FiO2 < 250 Acute Respiratory Distress Syndrome in the  absent 
    of pneumonia) or (PaO2 / FiO2 < 200 in Acute Respiratory Distress 
    Syndrome the present of pneumonia)
2. Acute Oliguria (urine output < 0.5 ml/Kg hr or 45mmol/L for at least 
    2hour)
3. Creatinine increase (0.5 mg/dL or 44.2 µmol/L from baseline)
4. Coagulopathy (INR > 1.5 or aPTT > 60secs)
5. Ileus (absent of bowel sound)
6. Thrombocytopenia (< 100, 000 µ/L)
7. Hyperbilirubinemia ( > 4mg/dL or 70 μmol/L)
8. Serum Lactate ( > upper limit of laboratory results)
Septic shock     Evident of sepsis with  Systolic blood pressure ≤ 90 mmHg after at    
    least 500 – 1000 mL of crystalloids (or 300 – 500 mL of colloids) fluid 
    challenge given over a 30-minute period
Sepsis induced hypoperfusion 1. Septic shock
2. Lactate ≥ 4mmol
3. Oliguria
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using Early Goal Directed Therapy 
(EGDT). After 28 days, a follow-up 
report was conducted via email, 
through case notes, or telephone call. 
Following that, patients were sort into 
two categories which are non-survivor 
or survivor as an outcome. 
STUDY SIZE
Power and sample size was calculated 
using Open Epi Version 3 based on 
Fleiss Statistic Method of Rate and 
Proportion. Calculation of sample 
size was based on preliminary serum 
lactate result of our local study, which 
the sensitivity is 75% and specificity is 
77%. For two-sided significant level, 
the percentage of general population 
included = 95%. Power of the study = 
80%. Odds ratio, the possibility to get 
disease if being exposed as compare to 
normal people = 4.9. Ratio of sample 
size exposed or unexposed = 1. Using 
Open Epi Version 3, by Fleiss Statistic 
Method of Rate and Proportion, we 
estimated that a minimum of 144 total 
cases would be necessary.
STATISTICAL METHOD
Statistical analyses were performed 
using SPSS version 20.0. The mean 
±standard deviation represents 
quantitative variables while number and 
percentage represent qualitative data. 
Kolmogorov-Smirnov test was used to 
test normal distribution of data. Fisher’s 
exact test was used in categorical 
variables while Mann-Whitney U was 
used in continuous variables test for 
comparison of survivors and non-
survivors. All tests used were two-
sided, and statistical significance was 
determined with p<0.05. Receiver-
operating characteristics (ROC) curves 
and area under the curve (AUC) were 
computed. 
RESULTS
CHARACTERISTIC OF STUDY 
COHORT
From March to April 2014, a total of 
375 patients admitted to Emergency 
Department were suspected with 
sepsis syndrome. From this amount, 
40 patients were eligible and recruited 
for this study. Twenty one patients 
were excluded (15 not consented, 
6 incomplete data collection). Total 
of 19 patients data were analyzed. 
Demographic data are provided in 
Table 2. 
STATIC LACTATE AND LACTATE 
CLEARANCE
The overall mortality for both group 
were 25% in lactate non clearance 
group versus 75% in lactate clearance 
group. The median static lactate for 
survivor and the non-survivor at H0, 
H1 and H6 are showed in Table 3. The 
results for lactate clearance percentage 
for both groups at H0-H1, H1-H6 and 
H0-H6 are showed in Table 4.  We 
found that the threshold for static 
lactate level to predict 28-day mortality 
in sepsis for H0, H1 and H6 were 
3.9mmol/L, 1.9mmol/L and 2.3mmol/L 
respectively (Table 5). The ROC curves 
for that lactate clearance are showed in 
Table 5.  
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DISCUSSION
STATIC LACTATE
All static lactate threshold level was 
significantly lower in the survivor 
group from the non-survivor at H0, 
H1 and H6. The median static lactate 
for survivor is significantly lower than 
the non-survivor at H0, H1 and H6 
(p<0.05) (Table 3).  Based on ROC 
curves, the AUR for at H0, H1 and H6 
Table 2: Demographic Data of Study Subject (N=19)
Overall population (N=19) Survivors (N=15) Non survivors (N=4)
Age (year), mean (±S.D) 53.89 (±23.11) 47.87 (±21.38) 76.50 (±14.38)
Gender (%)
Male 10(52.63) 9 (47.37) 1 (5.26)
Female 9(47.37) 6 (31.58) 3 (15.79)
Race, n (%)
Malay 11(57.89) 9 (47.37) 2 (10.53)
Chinese 7 (36.84) 5 (26.32) 2 (10.53)
Indian 1 ( 5.26) 1 (5.26) 0 (0.00)
Sepsis Origin (%)
Pulmonary 4 (21.05) 3 (15.79) 1 (5.26)
Digestive 5 (26.32) 3 (15.79) 2 (10.53)
Urinary 3 (15.79) 3(15.79) 0 (0.00)
Nervous system 1 (5.26) 0 (0.00) 1 (5.26)
Other 6 (31.58) 6(31.58) 0 (0.00)
Organ Failure, n (%)
Renal (Creatinine) 1 (5.30) 1 (5.26) 0 (0.00)
Coagulopathy 1 (5.30) 1 (5.26) 0 (0.00)
Serum Lactate 3 (15.79) 1 (5.26) 2 (10.53)
None 16 (84.21) 15 (78.95) 2 (10.53)
Severity of Sepsis, n (%)
Sepsis 13 (68.4%) 12 (63.16) 1 (5.26)
Severe Sepsis 4 (21.1%) 1 (5.26) 3 (15.79)
Septic shock 2 (10.5%) 2 (10.53) 0 (0.00)
Mortality 15 (78.95%) 4 (21.05%)
Table 3: Static lactate between survival and deceased, median (IQR)
Survivor (n=15)
Median, mmol/L (IQR)
Non survivors (n=4) 
Median, mmol/L (IQR)
P value
SL H0 1.9(1.2-3.3) 5.3 (3.1-16.0) 0.03 *
SL H1 1.4 (1.2-1.7) 3.9 (2.5-14.8) 0.01 *
SL H6 1.3 (1.0-2.0) 3.2 (2.5-4.0) 0.01 *
IQR interquartile range; SL static lactate; H0 blood lactate at 0 hour; H1 blood lactate at 1 hour; H6 blood 
lactate at 6 hour *statistically significant (p<0.05)
130
Med & Health 2014; 9(2): 124-133 Tan T.L. et al.
suggested that static lactate as a good 
prognostic tool to predict in 28 days 
mortality for sepsis. The difference of 
static lactate between survivors and 
non-survivors suggests that higher static 
lactate associates with the increment of 
mortality rate. Initial static lactate level 
does correlate with mortality rate thus 
provides a good prognosis for sepsis 
(3.85 mmol/L). 
LACTATE CLEARANCE – A TOOL 
FOR MONITORING SEPSIS?
In our study, despite there is a lactate 
reduction trend at H6, lactate clearance 
showed a weak association in predicting 
28-day mortality in sepsis patients which 
supports similar findings by Marty et al. 
(2013). The most plausible explanations 
for lactate clearance are the increased 
lactate removal, decreased lactate 
Table 4: Lactate clearance between survival and deceased, median (IQR)
Survivors (n=15) Non survivors (n=4) P value
LC H0-H1 Median, mmol/L 
(IQR)
0.5 (0.1-1.4) 1.2 (0.5-1.5) 0.40
Percentage 
Clearance %, (IQR)
30% (5.6-41.5) 19% (6.9-27.1) 0.42
LC H1-H6 Median, mmol/L 
(IQR)
0.3 (-0.5-0.6) 0.7 (0.0-10.9) 0.21
Percentage 
Clearance %, (IQR)
15% (-41.2-27.3) 17% (-1.2-64.0) 0.58
LC H0-H6 Median, mmol/L 
(IQR)
0.7 (-0.1-1.5) 2.1 (0.6-12.0) 0.15
Percentage 
Clearance %, (IQR)
38% (-10.0-50.0) 39% (14.5-69.7) 0.48
IQR interquartile range; LC Lactate Clearance ; H0-H1 blood lactate at 0 hour-blood lactate at 1 hour; H0-
H6 blood lactate at 0 hour-blood lactate at 6 hour; H1-H6 blood lactate at 1 hour-blood lactate at 6 hour
Table 5: The association between static lactate and lactate clearance to predict 28-day 
all cause mortality rate.
AUC 
(CI=95%)
Threshold 
(mmol /L)
Se. 
(CI=95%)
Sp. 
(CI=95%)
PPV 
(CI=95%)
NPV 
(CI=95%)
LR 
(CI=95%)
OR 
(CI=95%)
P 
Value
SL H0 0.867 
(0.67-1.00)
3.9 86.7% 
(59.5-97.9)
75.0 
(20.3-95.9)
92.9% 
(66.1-98.8)
60.0% 
(15.4-93.5)
0.2 
(0.0-0.7)
3.5 
(0.6-19.2)
0.04
SL H1 0.917 
(0.79-1.00)
1.9 80.0% 
(51.9-95.4)
99.9.% 
(40.2-100.0)
99.9% 
(73.4-100.0)
57.1 
(18.8-89.6)
0.2 
(0.1-0.6)
- 0.01
SL H6 0.908 
(0.77-1.00)
2.3 80.0% 
(51.9-95.4)
99.9% 
(40.2-100.0)
99.99% 
(73.4-100.0)
57.1% 
(18.8-89.6)
0.2 
(0.1-0.6)
- 0.01
LC 
H0-H1
0.633 
(0.39-0.88)
25.9 60.0% 
(32.3-83.6)
75.0% 
(20.3-95.8)
90.0 
(55.5-98.3)
33.3 
(7.8-69.9)
0.5 
(0.2-1.2)
2.4 
(0.4-13.8)
0.25
LC 
H0-H6
0.383 
(0.07-0.70)
36.3 53.3% 
(26.7-78.7)
50.0% 
(8.3-91.7)
80.0 
(44.4-96.89)
22.2 
(3.5-59.9)
0.9 
(0.3-2.9)
1.1
 (0.4-3.2)
0.67
LC 
H1-H6
0.400 
(0.09-0.71)
11.6 60.0% 
(32.3-83.6)
50.0%
(32.3-83.6)
81.8 
(48.2-97.2)
25.0 
(3.9-64.9)
0.8 
(0.2-2.6) 
1.2 
(0.4-0.5)
0.57
AUC area under the curve; Se. sensitivity;  Sp. Specificity ;  PPV positive predictive value; NPV negative predictive value; LR 
likelihood ratio; OR odd ratio; CI Confidence Interval; SL Lactate Clearance;  LC Lactate Clearance ; H0 blood lactate at 0 
hour; H1 blood lactate at 1 hour; H6 blood lactate at 6 hour; H0-H1 blood lactate at 0 hour-blood lactate at 1 hour; H0-H6 
blood lactate at 0 hour-blood lactate at 6 hour; H1-H6 blood lactate at 1 hour-blood lactate at 6 hour
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production, and dilatation effect due to 
fluid resuscitation (Jones 2011). Many 
studies showed that the rise of lactate 
production after initial resuscitation 
effort could be due to activation 
of glycolytic pathway triggered by 
mechanism such as Na+/K+-ATPase 
rather than the impact of tissue hypoxia 
(Hernandez et al. 2010, Gutierrez & 
Wulf 1996, James et al. 1999, Hotchkiss 
& Karl 1992, O’Brien et al. 1996). It is 
also suggested that high initial lactate 
levels had caused irreversible organ 
damage (Jansen et al. 2009). Thus, 
aggressive resuscitations are doubtful 
to reduce the impact of tissue damage 
caused initial high static lactate. 
Besides that, lactate is also a delayed 
indicator of tissue perfusion which 
the mechanism is yet to be elucidated 
(Marty et al. 2013). Age is a possible 
confounder for static lactate predicting 
28-day mortality. Further regression 
analysis should be carried out in the 
larger sample size to elucidate this 
trend.
 This study supports recommendation 
by survival sepsis campaign, which 
suggests the EGDT should be initiated 
on patients with static lactate more than 
4.0 mmol/L (Hernandez et al. 2010). 
Interestingly, static lactate at H1 has a 
threshold 1.9 mmol/L, and it appears to 
be lower compared with H0 and H6. 
It may have two possible explanations. 
First, it may reflect the successful of 
aggressive resuscitation. Secondly, the 
dilution effect of fluid resuscitation may 
lower the lactate level. This marked 
depression of lactate is not preserved 
throughout the treatment period. This 
reflected the resuscitation effort may 
have slowed down after patient was 
more stable after the achieving a lower 
static lactate level at H1.
LIMITATION OF STUDY
There were few limitations to be 
considered in this study. First of all, 
this study was done in one hospital, 
this might have influenced the results. 
Our study may introduce a selection 
bias that was difficult to account for. 
We were unable to keep track and 
take the blood samples on time as the 
acutely ill patient was highly mobile in 
ED to different zone from time to time 
according to their dynamic of the illness 
during the recruitment. We were also 
facing difficulty in getting the consent 
from the acutely ill patient in the absent 
of the next of kin. We tried to include 
as many patients as possible who have 
fulfilled the sepsis criteria to achieve 
the estimated sample size (n = 144). 
However, targeted sample size was 
partially achieved. The accrual time 
to reach 144 patients was estimated 
to be 24 months. It is possible that a 
larger study may result in different 
conclusion. The age profile cannot be 
met as demographic data shows non-
survivors appeared in older age group. 
It prevents further modeling to be 
performed. Information bias is possible 
because some information may not 
have been properly recorded. 
CONCLUSION
Our data has shown that with limited 
number of samples, static lactate was 
found to be useful to determine survival 
of sepsis patients. In our centre, static 
lactate remained as a strong dependent 
predictor for sepsis in hospital death. In 
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our study, static lactate is suggested to 
be superior over lactate clearance as a 
predictor for sepsis in 28 days mortality. 
However, lactate clearance can be a 
useful tool to monitor the resuscitation 
effort. 
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